Bono in­vests in biotech? Pep­tide play­er is head­ed to the US — with celebri­ty in­vestors back­ing its move

Even celebri­ties are piqued by biotech these days. For Bono and The Edge, it ap­pears they’ve found what they’re look­ing for — and they’re will­ing to put their mon­ey on it.

The Irish pep­tide biotech Nu­ri­tas closed a $45 mil­lion Se­ries B, an event which gained some added ex­po­sure through their front men from Dublin: U2’s The Edge and the man him­self — Bono.

Nu­ri­tas’s round, led by Chica­go-based in­vestor Cleve­land Av­enue, in­cludes the Eu­ro­pean Cir­cu­lar Bioe­con­o­my Fund (ECBF), Ver­tex Hold­ings and more. The Se­ries B al­so more than dou­bles what Nu­ri­tas had raised pre­vi­ous­ly, bring­ing the biotech to $75 mil­lion raised in to­tal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER